• Users Online: 249
  • Print this page
  • Email this page


 
 Table of Contents  
LETTER TO THE EDITOR
Year : 2020  |  Volume : 4  |  Issue : 3  |  Page : 167

Precision oncology innovation: Sarcoma as an example


Medical Health Colleges and Nursing, Al Rayan Medical Colleges, Al Madinah Al Manawarah, Saudi Arabia

Date of Web Publication07-Jul-2020

Correspondence Address:
Prof. Ali A Mustafa
Medical Health Colleges and Nursing, Al Rayan Medical Colleges, AlHigra Road, Al Madinah Al Manawarah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jmsr.jmsr_35_20

Rights and Permissions

How to cite this article:
Mustafa AA. Precision oncology innovation: Sarcoma as an example. J Musculoskelet Surg Res 2020;4:167

How to cite this URL:
Mustafa AA. Precision oncology innovation: Sarcoma as an example. J Musculoskelet Surg Res [serial online] 2020 [cited 2020 Oct 22];4:167. Available from: https://www.journalmsr.com/text.asp?2020/4/3/167/284598



Dear Editor,

I read the article about Precision Oncology, which was published in The Journal of Musculoskeletal surgery and research, in February 2020, with much interest and appreciation for the authors' succinct review.[1]

This review article is written with a clear command of the new trends of genomic technologies used in Precision Medicine. This is specially tailored to the treatment of sarcomas.

Advancement in the knowledge of basic sciences, tumorigenic processes/pathways, and potential targetable receptors or biomarkers is essential. This will enable the scientific community to select appropriate targets or biomarkers to individualize treatment regimes. The improved understanding of the genomic causes of each disease is allowing scientists to identify potential novel therapies rapidly. These new therapies may have the ability to change treatment paradigms over the coming years.

Whether you call it Precision Medicine or Personalized Medicine or Precision oncology, it is indeed the future of cancer treatment. Precision oncology will undoubtedly be the standard in health care, in the near future. This field is led by Europe and the US, making Precision Medicine a reality.

The European Society for Medical Oncology made a statement typifying the new trend in cancer management by quoting the phrase “Personalized management is considered as the future of cancer care.”[2]

Therefore, genetic and biomarker screening at the time of diagnosis will need to become the norm for all cancer diagnoses to determine individualized treatment regimens.[3]

The authors of the article, therefore, shed light on a topical issue in the management of cancer using targeted therapy. I expect many reviews along these lines will be seen to help physicians in their fight against this formidable disease.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Alhejaily AM, Salem RO. Precision oncology innovation: Sarcoma as an example. J Musculoskelet Surg Res 2020;4:3-8.  Back to cited text no. 1
  [Full text]  
2.
Yates LR. The “European Society for Medical Oncology” (ESM)Precision Medicine. Glossary. Annn Oncol 2018;29:30-5.  Back to cited text no. 2
    
3.
Haque SU, Morton D, Welch H. Biologics against cancer-specific receptors – Challenges to personalised medicine from early trial results. Curr Opin Pharmacol 2012;12:392-7.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed212    
    Printed34    
    Emailed0    
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]